BioPharma Clinical Trials
AbbVie Provides FDA and EMA Updates on Epcoritamab for Lymphoma Treatment
Updates are supported by data from the Phase 1/2 EPCORE™ NHL-1 clinical trial AbbVie announced updates from the U...
November 29, 2023 | News
Everest Medicines Gets NMPA Approval for Nefecon® in China for IgA Nephropathy
--Nefecon® is the first approved medicine with an IgAN indication in China-- --The approval marks a new era of IgAN treatment for Chinese patient...
November 27, 2023 | News
DxVx Plans License-In of OVM-200, Launches Clinical Trials in Asia
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK- DxVx plans to proceed its own clinical trials in Asia, including Korea and Chi...
November 27, 2023 | News
Simcere and Connect ink exclusive deal for autoimmune drug Rademikibart.
Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...
November 24, 2023 | News
BeiGene and Ensem Therapeutics Partner to Advance CDK2 Inhibitor
“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...
November 23, 2023 | News
Senhwa Biosciences Granted FDA IND for Phase II Study of Silmitasertib in Viral Community-Acquired Pneumonia (CAP)
The trial is a phase II multi-center, randomized-controlled interventional prospective study, and the purpose of this trial is to investigate whether ...
November 22, 2023 | News
Micron Biomedical Secures $23.6M to Advance Needle-Free Vaccine Production for Measles Eradication
Micron has received this grant from the Bill & Melinda Gates Foundation to fund mass production of needle-free vaccines utilizing Micron technology t...
November 20, 2023 | News
Clinical trial expands evidence base for the Wobenzym® brand
A recent clinic trial is expanding the evidence base for the Wobenzym® brand. The results are published in Therapeutic Advances in Musculoske...
November 19, 2023 | News
ACROBiosystems Introduces GM-Grade DLL4 Protein for Faster Stem Cell Manufacturing
The availability of DLL4 manufactured under GMP conditions represents a significant milestone for enterprises engaged in developing or manufacturing stem-c...
November 17, 2023 | News
TB Alliance Initiates Phase 2 Trial for Next-Gen TB Drug in Five Countries
Early results presented at the Union World Conference on Lung Health suggest promise of new compound to fight tuberculosis that will be tested as part of P...
November 17, 2023 | News
Telix, an Australian Company, Announces Planned Acquisition of QSAM Biosciences and its Lead Therapy Candidate, CycloSam
CycloSam® is highly synergistic with Telix's existing therapeutic development activity in both prostate cancer and sarcoma. The proposed acquisiti...
November 14, 2023 | News
George Clinical and Medidata Partner in Australia to Boost Operational Efficiency in Clinical Trials
Medidata, a Dassault Systèmes company, announced that George Clinical, a leading global clinical research organization, is leveraging Medidata's clo...
November 14, 2023 | News
PharmAbcine Advances PMC-403 Clinical Trial in South Korea for Macular Degeneration
Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment. The starting dose (0.7m...
November 10, 2023 | News
Medidata Introduces Clinical Data Studio and Health Record Connect for Faster Clinical Trials
-Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced new experienc...
November 09, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
